Farmacia italiana online: acquisto cialis in Italia e Roma senza ricetta.

Sds

SAFETY DATA SHEET
1: IDENTIFICATION OF THE SUBSTANCE / PREPARATION AND OF THE COMPANY /
UNDERTAKING

Product Name: NITOMORTAR PE CATALYSED FILLER
Filler component of two part polyester resin jointing and repair compound.
Fosroc Limited
Coleshill Road, Tamworth, Staffordshire. B78 3TL 2: COMPOSITION/INFORMATION ON INGREDIENTS
silica sands, inert fillers, benzoyl peroxide.
All constituents of this product are listed in EINECS (European Inventory of Existing Commercial Chemical Substances)or ELINCS (European List of New Chemical Substances) or are exempt.
Refer to Section 8 for Occupational Exposure Limits.
3: HAZARDS IDENTIFICATION
May cause sensitisation by skin contact.
4: FIRST AID MEASURES
Irrigate immediately with copious quantities of water for several minutes. Obtain medical attention ifirritation persists.
Wash thoroughly with soap and water or suitable skin cleanser as soon as possible.
Remove from exposure - unlikely to occur.
Wash out mouth with water. Do NOT induce vomiting. Obtain medical attention.
5: FIRE FIGHTING MEASURES
Suitable Extinguishing Media:
Carbon dioxide, powder, foam or water fog - Do not use water jets.
6: ACCIDENTAL RELEASE MEASURES
Wear suitable protective clothing, gloves and eye/face protection.
Prevent entry into drains, sewers and water courses.
Gather into containers. Avoid the creation of dust in atmosphere.
7: HANDLING AND STORAGE
Avoid breathing dust. Avoid skin and eye contact.
Store away from acids. Store away from alkalis. Keep containers dry and tightly closed.
8: EXPOSURE CONTROLS/PERSONAL PROTECTION
Issue No:
Date: 12.05.97
In case of insufficient ventilation wear suitable respiratory equipment. Avoidskin and eye contact. Impervious gloves (eg PVC). Safety glasses.
9: PHYSICAL AND CHEMICAL PROPERTIES
10: STABILITY AND REACTIVITY
Thermal decomposition:- Carbon monoxide.
11: TOXICOLOGICAL INFORMATION
The following toxicological assessment is based on a knowledge of the toxicity of the product's components.
Oral LD50, rat 5000mg/kg.
Health Effects
On Eyes:
Irritating and may injure eye tissue if not removed promptly.
Repeated or prolonged contact with abraded or damaged skin may cause allergic skin reaction insusceptible people. May cause sensitisation.
By Inhalation: Irritating to respiratory system.
By Ingestion: May cause irritation of mouth, throat and digestive tract.
Repeated and prolonged skin contact may lead to skin disorders.
12: ECOLOGICAL INFORMATION
When used and disposed of as intended, no adverse environmental effects areforeseen.
Persistence and Degradability: Expected to be readily biodegradable.
Bioaccumulative Potential: Not expected to be ecotoxic to fish/daphnia/algae.
13: DISPOSAL CONSIDERATIONS
Disposal must be in accordance with local and national legislation.
Issue No:
Date: 12.05.97
Dispose of through an authorised waste contractor to a licensed site.
The method of disposal must be acceptable to the local authority.
14: TRANSPORT INFORMATION
This product is NOT classified as dangerous for transport.
15: REGULATORY INFORMATION
Hazard Label Data:-
Named Ingredients:
May cause sensitisation by skin contact.
Do not breathe dust.
In case of contact with eyes, rinse immediately with plenty of water and seek medicaladvice.
Wear suitable gloves and eye/face protection Dangerous Substances Directive, 67/548/EEC and adaptations.
Dangerous Preparations Directive, 88/379/EEC.
Safety Data Sheets Directive, 91/155/EEC.
Chemicals (Hazard Information and Packaging for Supply) (Amendment) Regs. 1996 (SI1092).
Environmental Protection (Duty of Care) Regs. 1991 (SI 2839).
Occupational exposure limits (EH 40).
The above publications are available from HMSO 16: OTHER INFORMATION
Also refer to the Safety Data Sheet(s) for information on other components of this product.
The data and advice given apply when the product is used for the stated application or applications. The product is not sold as suitable for any otherapplication. Use of the product for applications other than as stated in this sheet may give rise to risks not mentioned in this sheet. The product shouldnot be used other than for the stated application or applications without seeking advice from Fosroc Ltd.
If this product has been purchased for supply to a third party for use at work, it is the purchaser's duty to take all necessary steps to secure that any personhandling or using the product is provided with the information in this sheet.
It is the responsibility and duty of the employer to inform employees and others who may be affected of any hazards described in this sheet and of anyprecautions which should be taken.
This sheet does not constitute or substitute for the users own assessment of workplace risk, as required by other health and safety legislation.
Further copies of this Safety Data Sheet may be obtained from Fosroc Limited.
REVISION
Supersedes issue no:
Issue No:
Date: 12.05.97

Source: http://www.arconsupplies.co.uk/productpdfs/ams/NitomortarPEFiller.pdf

Definition and determination

ALLERGY INFORMATION MEDICATION AND IMPLICATIONS Nitric oxide is a biomarker for inflammatory mediators that reflect activity of the eosinophils, which are the main marker for severity of inflammation in asthma. The definitive test is a BAL (bronchialalveolar lavage) of eosinophils, which correlates with effectiveness of inhaled steroids. FeNO (fractional exhaled nitric oxide) can n

Microsoft word - butanoxm-50_ts_row_eng_pds.doc

Product Data Sheet Curing Agents Butanox ® M-50 Product description Methyl ethyl ketone peroxide, solution in dimethyl phthalate Specifications Characteristics Due to the relatively unstable nature of organic peroxides a loss of quality can be detected over a period of time. To minimize the loss of quality, Akzo Nobel recommends a maximum storage temperature (Ts max.)

Copyright © 2010-2014 Pdf Pills Composition